Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Neurosci Biobehav Rev. 2018 Nov 22;99:160–197. doi: 10.1016/j.neubiorev.2018.11.010

Table A.2.

Assessment of Human Trial Quality: PEDro Scale*.

Reference 1.
Eligibility
criteria
specified
2.
Random
allocation
3.
Concealed
allocation
4.
Groups
similar
at
baseline
5.
Subject
blindig
6.
Therapist
blinding
7.
Assess
or
blinding
8. Less
than
15%
dropouts
9.
Intention
-to-
treat
analysis
10.
Between-
group
statistical
comparisons
11.
Point
measures
and
variability
data
Totala
Infant/Child
(Rinne et al., 2006) 1 1 1 0 1 1 1 0 0 1 1 8
(Indrio et al., 2014) 1 1 1 1 1 1 1 0 0 1 1 9
(Cekola et al., 2015) 1 1 1 1 1 1 1 0 1 1 1 10
(Sung et al., 2014) 1 1 1 1 1 1 1 0 1 1 1 10
(Weizman and Alsheikh, 2006) 1 1 1 1 1 1 1 0 1 1 1 10
(Akar et al., 2017) 1 1 1 1 1 1 1 0 0 1 1 9
(Ringel-Kulka et al., 2015) 1 1 1 0 1 1 1 0 1 1 0 8
Older Adult
(Ostlund-Lagerstrom et al., 2016) 1 1 1 1 1 1 1 1 1 1 1 11
(Benton et al., 2007) 1 1 1 1 1 1 1 1 0 1 1 10
(Chung et al., 2014) 1 1 1 0 1 1 1 1 0 1 1 9
(Pellino et al., 2013) 1 1 1 1 1 1 1 1 1 1 0 10
(Akbari et al., 2016) 1 1 1 1 1 1 1 1 1 1 1 11
Young/Middle-Aged Adult
(Kato-Kataoka et al., 2016) 1 1 1 1 1 1 1 1 0 1 1 10
(Takada et al., 2016) 1 1 1 1 1 1 1 1 0 1 1 10
(Takada et al., 2017) 1 1 1 1 1 1 1 1 0 1 1 10
(Rao et al., 2009) 1 1 1 0 1 1 1 1 0 1 0 8
(Reale et al., 2012) 1 1 1 1 1 1 1 1 0 1 1 10
(Bajaj et al., 2014) 1 1 1 1 1 1 1 0 1 1 1 10
(Kelly et al., 2017) 1 1 1 1 1 0 0 0 0 1 1 7
(Sanchez et al., 2017) 1 1 1 1 1 1 1 0 1 1 1 10
(Michalickova et al., 2016) 1 1 1 1 1 1 1 0 0 1 1 9
(Culpepper et al., 2016; Langkamp-Henken et al., 2015) 1 1 1 1 1 1 1 1 1 1 1 11
(Slykerman et al., 2017) 1 1 1 1 1 1 1 1 1 1 1 11
(Childs et al., 2014) 1 1 1 1 1 1 1 1 0 1 1 10
(Choi et al., 2011) 1 1 1 1 1 1 1 0 0 1 1 9
(Lorenzo-Zuniga et al., 2014) 1 1 1 1 1 1 1 0 1 1 1 10
(Lyra et al., 2016) 1 1 1 1 1 1 1 1 1 1 1 11
(Spiller et al., 2016) 1 1 1 1 1 1 1 0 1 1 1 10
(Dapoigny et al., 2012) 1 1 1 1 1 1 1 1 1 1 1 11
(Nishihira et al., 2014) 1 1 1 1 1 1 1 1 0 1 1 10
(Nobutani et al., 2017) 1 1 1 1 1 1 1 1 0 1 1 10
(Pinto-Sanchez et al., 2017) 1 1 1 0 1 1 1 1 1 1 1 10
(Yang et al., 2016b) 1 1 0 1 1 0 0 1 1 1 1 8
(Fujimori et al., 2009) 1 1 1 1 1 1 1 0 0 1 1 9
(Steenberg en et al., 2015) 1 1 1 1 1 1 1 1 0 1 1 10
(Moller et al., 2017) 1 1 1 0 1 1 1 0 0 1 1 8
(Tillisch et al., 2013) 1 1 1 1 1 1 1 0 0 1 1 9
(Mohammadi et al., 2016) 1 1 1 1 1 1 1 1 0 1 1 10
(Messaoudi et al., 2011a; Messaoudi et al., 2011b) 1 1 1 0 1 1 1 0 0 1 1 8
(Diop et al., 2008) 1 1 1 0 1 1 1 1 1 1 1 10
(Romijn et al., 2017) 1 1 1 0 1 1 1 1 1 1 1 10
(Akkasheh et al., 2016) 1 1 1 1 1 1 1 1 1 1 1 11
(Dickerson et al., 2014; Severance et al., 2017; Tomasik et al., 2015) 1 1 0 1 1 0 0 1 0 1 1 7
(De Lorenzo et al., 2017) 1 1 1 0 1 1 1 1 1 1 1 10
(Kouchaki et al., 2016) 1 1 1 1 1 1 1 1 1 1 1 11
(Feher et al., 2014) 1 1 0 0 1 0 0 0 0 1 1 5
(Lee et al., 2014) 1 1 1 1 1 1 1 1 0 1 1 10
(Malaguarnera et al., 2010) 1 1 1 1 1 1 1 0 0 1 1 9
*

As reported by Maher et al. (2003).

a

Mean total score = 9.5 (SD 1.2). Interquartile range 9-11.